Covid revenue cliff is mostly behind them. The stock is cheap at 12x earnings. Seagen acquisition gives them oncology exposure. Turnaround play for patient investors.

Dividend yield of 6% is a yellow flag. The market is telling you the dividend might not be safe if earnings don't recover. Pipeline is thin.